TNFRSF1B and neoplasm: IAP antagonists can activate autocrine TNF production in a subset of tumour cells.26, 27, 28, 29 We successfully inhibited TNF-mediated apoptosis in previous studies5 as well as our control conditions (Supplementary Figure 3A–D) by recombinant TNFR2-Fc.